The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Geffken Daniel E. since 2020.
This trader's CIK number is 1314756.
At the time of last reporting, Geffken Daniel E. was the INTERIM CFO of Eloxx Pharmaceuticals, Inc.. (stock ticker symbol ELOX).
Also see all insider trading activities at Eloxx Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | WINT | 2,069 | $15,000 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | ELOX | 50,000 | $36,000 | 0 | $0 | 0 | $0 |
1. Windtree Therapeutics Inc /de/ (WINT)
2. Eloxx Pharmaceuticals, Inc. (ELOX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-05-22 | WINT | Buy | 2,069 | 7.25 | 15,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-11-29 | ELOX | Buy | 50,000 | .72 | 36,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Geffken Daniel E. (INTERIM CFO of Eloxx Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.